Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma

Clinical trial NCT01236560 · COMPLETED

Trial details

NCT number: NCT01236560
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Brain Stem Glioma Cerebral Astrocytoma Childhood Cerebellar Anaplastic Astrocytoma Childhood Cerebral Anaplastic Astrocytoma Childhood Spinal Cord Neoplasm

Start date: 2011-01-26
Primary completion: 2023-06-30
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.